• About Us
    • Company History
    • Our Mission
    • Management Team
    • Board of Directors
  • Technology
    • The Problem
    • The Solution: Our Microbial Platforms
      • C1
      • Dapibus™
    • Advantages and Opportunities
  • Pipeline
    • Human Health
    • Animal Health
    • Alternative Proteins
  • Partners
  • Investors
    • Overview
    • Press Releases
    • SEC Filings
    • Financials
    • Investor Fact Sheet
    • Analyst Coverage
    • Corporate Governance
    • Annual Meeting and Proxy
    • Stock Information
    • Earnings Calls
    • Email Alert Opt-in
  • Media
    • Articles
    • Events
    • Presentations
    • Press Releases
    • Scientific Publications
    • Video Gallery
  • Contact Us

testing

sdfsdf

Recent Posts

  • Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
  • Dyadic to Present at World Vaccine Congress | Washington
  • Dyadic Reports 2024 Year-End Financial Results and Business Updates
  • Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines
  • Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025

Recent Comments

No comments to show.

Sign up for communications from Dyadic

Stay informed and receive company updates straight to your inbox.

Signup

Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and accessible biopharmaceutical and bio-industrial products for human and animal health and alternative proteins.

  • About Us
    • Company History
    • Our Mission
    • Management Team
    • Board of Directors
  • Technology
    • The Problem
    • The Solution: Our Microbial Platforms
      • C1
      • Dapibus™
    • Advantages and Opportunities
  • Pipeline
    • Human Health
    • Animal Health
    • Alternative Proteins
  • Partners
  • Investors
    • Overview
    • Press Releases
    • SEC Filings
    • Financials
    • Investor Fact Sheet
    • Analyst Coverage
    • Corporate Governance
    • Annual Meeting and Proxy
    • Stock Information
    • Earnings Calls
    • Email Alert Opt-in
  • Media
    • Articles
    • Events
    • Presentations
    • Press Releases
    • Scientific Publications
    • Video Gallery
  • Contact Us
© 2025 Dyadic International Inc